Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3pomalidomide 2interferon alfa-n1 2liposomal doxorubicin 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Sorafenib 1Pentoxifylline 1O-(Chloroacetylcarbamoyl)fumagillol 1Nivolumab 1Muromonab-CD3 1Methotrexate 1Leucovorin 1Isotretinoin 1Interleukin-4 1Interleukin-2 1Interferon beta-1b 1Etoposide 1Didanosine 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cidofovir 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Acquired Immunodeficiency Syndrome × Interferon beta-1b × Clear all
NCT00000695 2021-11-02

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
36 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡